Initial Real-World Experience of Tricuspid Transcatheter Edge-to-Edge Repair in Asia.

ABSTRACT:

Background

Tricuspid regurgitation (TR) causes significant morbidity. Transcatheter edge-to-edge repair (TEER) has been proven effective in relieving TR symptoms. Access to tricuspid TEER and the associated experience are limited in Asia.

Objectives

This study aimed to summarize the initial experience with the tricuspid TEER system (Abbott) in Asia.

Methods

Patients undergoing tricuspid TEER (Abbott) from 2017 to 2024 were enrolled from 4 centers in Asia. The primary endpoint was device success (TR ≤moderate) at 30 days. Secondary endpoints included inpatient complications, 30-day NYHA functional class, and 30-day major adverse events. Risk factors for 30-day device success were identified.

Results

A total of 106 patients were included, with a mean age of 76.1

SUBMITTER: So KC 

PROVIDER: S-EPMC12833604 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature